PT - JOURNAL ARTICLE AU - Sarfraz Saleemi AU - Reem Alameer AU - Toka Alsulaim AU - Naif S Alghasab TI - Anxiety and Depression in Patients with Pulmonary Hypertension and its Impact on Health-Related Quality of Life AID - 10.1101/2021.04.22.20232645 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.22.20232645 4099 - http://medrxiv.org/content/early/2021/04/22/2021.04.22.20232645.short 4100 - http://medrxiv.org/content/early/2021/04/22/2021.04.22.20232645.full AB - Background Pulmonary Hypertension (PH) is a chronic progressive disease which affects quality of life. The prevalence of mood disorders in PH patients in Saudi Arabia is not known.Objectives This is a prospective observational study to investigate the prevalence of anxiety and depression in patients with pulmonary hypertension and its effect on health-related quality of life (HRQoL).Methods Forty-two PH patients were evaluated for mood disorders by using Hospital Anxiety and Depression Scale (HADS) and health related quality of life was assessed with The Short Form 36 (SF-36) Health Survey questionnaire.Results Mean age for the cohort was 42.8 (±13.3) years and 31(73%) were female. Mean pulmonary artery pressure was 46.4 (± 15) mm Hg and 25 (60%) patients had severe PH (mPAP ≥45 mmHg). Thirty-eight (90%) patients were in World Health Organization Functional Class (WHO-FC) II/III and 5 (10%) class IV. HADS anxiety and depression score was positive (11-21) in 4 (10%) and 6 (14%) patients respectively. Presence of anxiety and/or depression affected HRQoL.Conclusion Prevalence of anxiety and depression in PH patients in Saudi Arabia is low (10% and 14% respectively) compared to published studies. The low prevalence may be explained by cultural and social differences and strong family support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was obtainedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Research Advisory Committee (RAC) of King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. The RAC is supported by four standing committees; the Research Ethics Committee (REC), the Clinical Research Committee (CRC), the Basic Research Committee (BRC), and the Animal Care and Use Committee (ACUC) and administratively by the Office of Research Affairs (ORA). This study received full approval from RAC including from Research Ethical Committee (REC). The REC, the Institutional Review Board (IRB), evaluates the ethical aspects of all research proposals that involve human subjects. Project Approval was granted with approval ID# 2161034All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is availablePHPulmonary HypertensionHADSHospital Anxiety and Depression ScaleHRQoLHealth Related Quality of LifeSF-36Short Form 36FCFunctional ClassmPAPmean Pulmonary Arterial PressurePVRPulmonary Vascular ResistancePCWPPulmonary Capillary Wedge Pressure